Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-25, Stock:ABT, The news for the past five days is as follows:
2019-03-18: NEWS1: Abbott (ABT) Stock Sinks As Market Gains: What You Should Know.
2019-03-19: NEWS1: Why You Should Buy ABBV Stock for Income and Value.NEWS2: Why You Should Buy ABBV Stock for Income and Value.NEWS3: Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results.NEWS4: Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results.NEWS5: What Makes Abbott (ABT) a New Buy Stock.NEWS6: What Makes Abbott (ABT) a New Buy Stock.NEWS7: Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results.NEWS8: Why You Should Buy ABBV Stock for Income and Value.NEWS9: 3 Blue Chip Stocks That Just Hit 52-Week Highs: Are They Buys?.NEWS10: 3 Blue Chip Stocks That Just Hit 52-Week Highs: Are They Buys?.NEWS11: Abbott Announces CE Mark for Alinity™ m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients.NEWS12: 3 Blue-Chip Stocks That Just Hit 52-Week Highs: Are They Buys?.
2019-03-20: NEWS1: Abbott Laboratories (ABT) Chairman and CEO Miles D White Sold $6 million of Shares.NEWS2: Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (revised).NEWS3: Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (revised).NEWS4: Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (revised).NEWS5: Abbott (ABT) Gains Ground on Solid EPD and Diabetes Arms.NEWS6: Medtronic (MDT) Releases Encouraging Evalut TAVR Result.NEWS7: Medtronic (MDT) Releases Encouraging Evalut TAVR Result.NEWS8: Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?.NEWS9: Medtronic (MDT) Releases Encouraging Evalut TAVR Result.NEWS10: Abbott (ABT) Gains Ground on Solid EPD and Diabetes Arms.NEWS11: Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (Revised).NEWS12: Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (Revised).NEWS13: Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?.NEWS14: Abbott Hosts Conference Call for First-Quarter Earnings.NEWS15: Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (Revised).
2019-03-21: NEWS1: Spruce Point: Dexcom Could Fall 45-60%.NEWS2: Big-data software firm Tresata's upcoming hackathon to tackle public health.NEWS3: Big-data software firm Tresata's upcoming hackathon to tackle public health.NEWS4: Edwards Lifesciences Presents Positive Partner 3 Trial Data.NEWS5: Edwards Lifesciences Presents Positive Partner 3 Trial Data.NEWS6: Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results.NEWS7: Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results.NEWS8: Notable ETF Outflow Detected - IWD, INTC, T, ABT.NEWS9: Notable ETF Outflow Detected - IWD, INTC, T, ABT.NEWS10: Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results.NEWS11: Edwards Lifesciences Presents Positive Partner 3 Trial Data.
2019-03-22: NEWS1: Varian (VAR) Scales New 52-Week High on Solid Prospects.NEWS2: Here's Why DexCom Shares Are Dropping Today.NEWS3: Here's Why DexCom Shares Are Dropping Today.NEWS4: Here&apos;s Why DexCom Shares Are Dropping Today.NEWS5: Baxter (BAX) Soars to 52-Week High, Time to Cash Out?.NEWS6: Baxter (BAX) Soars to 52-Week High, Time to Cash Out?.

Answer: Rise